NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy
NeuroCytonix, Inc. (the "Company" or "NeuroCytonix") today announced that on January 19, 2023, its subsidiary NeuroCytonix Mexico has...
Read disclosure →Corporate Disclosures & Press Wire (1)